Skip to content

MAZE MAZE Interest Income

Interest Income at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$5.03M+12.8%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.78M+5.6%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$5.32M-18.3%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$2.47M+205%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.35M-31.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.74M+11.5%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's interest income?
MAZE (MAZE) reported interest income of $3.21M in Q1 2026.
How has MAZE's interest income changed year-over-year?
MAZE's interest income increased by 22.8% year-over-year, from $2.62M to $3.21M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.